文献速递中枢神经肿瘤放疗放疗物理与技术

HyperArc 在单发胶质母细胞瘤推量放疗中的剂量学质量:与射波刀和手动 VMAT 的比较

Dosimetric quality of HyperArc in boost radiotherapy for single glioblastoma: comparison with CyberKnife and manual VMAT.
PubMed 文献 · Radiat Oncol · 2023-01-10

本研究纳入本中心 16 例临床射波刀(CK)计划患者,在计算机中设计基于直线加速器的 HyperArc(HA)和手动 VMAT 计划,比较单发大靶区推量放疗的剂量学质量。HA 计划适形指数更高(0.94±0.03)、梯度指数更低(2.57±0.53),危及器官和正常组织受量更低;CK 计划均匀性指数更高(0.35±0.10)且肿瘤内剂量更高;HA 平均可节省 CK 一半的出束时间(37 分钟)。

要点

  • HA 计划适形指数 0.94±0.03、梯度指数 2.57±0.53,危及器官和正常组织受量更低。
  • CK 计划均匀性指数 0.35±0.10,肿瘤内剂量更高。
  • 手动 VMAT 剂量质量略有改善且机器跳数更少(2083±225),HA 平均节省 CK 一半出束时间(37 分钟)。

核心结论

  • HA 计划适形性更高且危及器官受量更低、正常组织照射更少,CK 计划肿瘤平均剂量更高。
  • HA 四弧规划在单发肿瘤的剂量学质量上足够,且相比常规 VMAT 在计划和治疗流程上更便捷。
  • 选择治疗设备时需考虑肿瘤大小和位置。

研究设计与样本

  • 纳入本中心 16 例临床 CK 计划治疗的患者,基于直线加速器的计划在计算机中设计。
  • 从正常组织保护和治疗疗效方面比较适形指数、梯度指数、均匀性指数、计划靶区剂量分布、正常脑组织剂量及多个危及器官的平均剂量。
  • 所有数据采用非参数 Kruskal-Wallis 检验评估,并进一步分析剂量分布与肿瘤体积及位置的关系。

主要发现

  • HA 计划适形指数更高(0.94±0.03)且梯度指数更低(2.57±0.53),危及器官和正常组织受量更低。
  • CK 计划均匀性指数更高(0.35±0.10),肿瘤内剂量更高。
  • 手动 VMAT 在剂量质量上略有改善且机器跳数更少(2083±225),HA 平均可节省 CK 一半的出束时间(37 分钟)。

关键数值与推荐

  • HA 计划适形指数 0.94±0.03、梯度指数 2.57±0.53。
  • CK 计划均匀性指数 0.35±0.10。
  • 手动 VMAT 机器跳数 2083±225,HA 平均节省 CK 出束时间 37 分钟的一半。

临床怎么用

  • HA 四弧规划在单发肿瘤的剂量学质量上足够,且相比常规 VMAT 在计划和治疗流程上更便捷。
  • 选择治疗设备时需考虑肿瘤大小和位置。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Stereotactic radiotherapy (SRT) and hypo-fractionated radiotherapy are feasible treatment options for single glioblastoma multiforme when combined with conventional radiotherapy or delivered alone. HyperArc (HA), a novel linac-based method with 4 noncoplanar arcs, has been introduced into stereotactic radiosurgery (SRS) for single and multiple metastases. In this study, we compared the dosimetric quality of HyperArc with the well-established CyberKnife (CK) and conventional VMAT methods of SRT for a single, large target. METHODS: Sixteen patients treated in our center with their clinical CK plans were enrolled, and the linac-based plans were designed in silico. From the aspect of normal tissue protection and treatment efficacy, we compared the conformity index (CI), gradient index (GI), homogeneity index (HI), dose distribution in planning target volume, dose in the normal brain tissue, and mean dose of several organs at risk (OARs). All of the data were evaluated with nonparametric Kruskal‒Wallis tests. We further investigated the relationship of the dose distribution with the tumor volume and its location. RESULTS: The results showed that with a higher CI (0.94 ± 0.03) and lower GI (2.57 ± 0.53), the HA plans generated a lower dose to the OARs and the normal tissue. Meanwhile, the CK plans achieved a higher HI (0.35 ± 0.10) and generated a higher dose inside the tumor. Although manual VMAT showed slight improvement in dose quality and less monitoring units (2083 ± 225), HA can save half of the delivery time of CK (37 minutes) on average. CONCLUSION: HA plans have higher conformity and spare OARs with lower normal tissue irradiation, while CK plans achieve a higher mean dose in tumors. HA with 4 arcs is sufficient in dosimetric quality for a single tumor with great convenience in planning and treatment processes compared with conventional VMAT. The tumor size and location are factors to be considered when selecting treatment equipment.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Pan M, Xu W, Sun L, et al. Dosimetric quality of HyperArc in boost radiotherapy for single glioblastoma: comparison with CyberKnife and manual VMAT. Radiat Oncol. 2023. PMID: 36627633. doi:10.1186/s13014-022-02150-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。